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What Structural Elements make a G-Quadruplex Physiologically Viable?
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As much as 375,000 potential G-Quadruplex forming sequences (PQS) have
been identified in the human genome nevertheless conclusive demonstration
of existence and relevance of these structures in vivo has been challenging.
Along with the abundance of the PQS, a variety of proteins have also been dem-
onstrated to efficiently destabilize G-Quadruplex (GQ) structures in vitro, sug-
gesting the possibility that most GQ forming PQS are rapidly identified and
unfolded by these proteins. In an attempt to perform a systematic study of
GQ-protein interactions we selected Replication Protein A (RPA) as a model
system and studied the interactions of RPA with 10 different GQ constructs
with varying loop lengths and number of tetrad layers. RPA is the most abun-
dant single strand DNA binding protein in eukaryotes, is involved in DNA rep-
lication and repair along with telomere maintenance, making it an ideal model
system for this study. Single molecule FRET and bulk biophysical methods
were used to perform these studies. Our results demonstrate a systematic in-
crease in the stability of GQ structures against RPA unfolding as the loop
lengths are shortened or the number of tetrad layers is increased. Certain GQ
constructs were completely unfolded at RPA concentrations several orders of
magnitude less than physiological RPA concentration, suggesting that they
would not be viable in vivo. Interestingly, the time it takes for an RPAmolecule
to unfold a GQ construct does not depend on the number of layers the GQ has,
suggesting that binding of RPA to GQ is the rate limiting step and that binding
affinity decreases as the number of layers is increased. The implications of our
data in terms of a molecular understanding of RPA-GQ interactions will be dis-
cussed along with our preliminary attempts to model this system.
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It is known that expanded CUG repeats arising from the DMPK gene sequester
the splicing protein MBNL1 and that this leads to myotonic dystrophy type I
(DM1). Herein, we describe the rational design and synthesis of a library of di-
mers that bind with high affinity to CUG repeats. Our goal is to disrupt
MBNL1-CUG repeat complex formation. Previously a CUG binding ligand,
containing a 1,3,5-triazine-2,4,6-triamine recognition unit linked to an acridine,
showed promising MBNL1-(CUG)12 inhibition potency.
The repeating nature of the aberrant RNA, prompted us to follow a bivalent ap-
proach through ligand dimerization in order to increase the affinity and selec-
tivity of the ligand. A small library of dimeric ligands was synthesized using
linkers with different lengths and functionality. Two different acridine substi-
tution patterns were also examined with the goal of optimizing the bivalent
effect. The ability of dimeric ligands to bind to (CUG)12 hairpin and inhibit
MBNL1-(CUG)12 complex formation was tested using various biophysical
techniques, including Tm measurement, isothermal titration calorimetry, sur-
face plasmon resonance, fluorescence studies and total internal reflection fluo-
rescence microscopy.
The most potent dimer, AJ8, contained N,N0-bis(3-aminopropyl)-1,3-propane-
diamine, as the linker and was found to inhibit the MBNL1-(CUG)12 complex
formation with an IC50 of 1.09 mM in the presence of excess tRNA as a com-
petitor. The inhibition potency is more than 200-fold greater than the corre-
sponding monomer leading to a bivalent effect that is greater than 100-fold.
Another advantage of AJ8 is improved drugability profile as it is not cell cyto-
toxic and unlike the corresponding monomer is aqueous soluble.
This study suggests a general approach by taking advantage of multivalent
effect for targeting disorders with repeating causative agents.
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A recent finding of a bacterial strain (GFAJ-1) that can rely on arsenic instead
of phosphorus raised the questions of if and how arsenate can replace phosphate
in biomolecules that are essential to sustain cell life. Apart from questions
related to chemical stability, there are those of the structural and functionalconsequences of phosphate-arsenate substitutions in vital nucleotides in
GFAJ1-like cells. In this study we selected three types of molecules (ATP/
ADP as energy source and replication regulation; DNA-protein complexes
for DNA replication and transcription initiation; and a tRNA-protein complex
and ribosome for protein synthesis) to computationally probe if arsenate nucle-
otides can retain the structural and functional features of phosphate nucleotides.
We further compared the experimental EXAFS spectra of the arsenic bacteria
with theoretical EXAFS spectra for arsenate DNA and rRNA. Our results dem-
onstrate that while it is possible that dried GFAJ-1 cells contain linear arsenate
DNA, the arsenate 70S ribosome does not contribute to the main arsenate de-
pository in the GFAJ-1 cell. Our study indicates that evolution has optimized
the inter-relationship between proteins and DNA/RNA, which requires overall
changes at the molecular and systems biology levels when replacing phosphate
by arsenate.
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Rev, a key regulatory protein of HIV-1, activates nuclear export of unspliced
and partially spliced viral mRNAs, which encode the viral genome and the
genes encoding viral structural proteins, respectively. Initially, a single Rev
monomer binds to a highly conserved region, stem IIB located on the Rev Re-
sponse Element (RRE) of viral mRNA. Following this nucleation step, addi-
tional Rev monomers are recruited to the RRE through a combination of
RNA-protein and protein-protein interactions, resulting in the formation of
a functional nuclear export complex. In addition, several cellular proteins,
such as the DEAD box helicases DDX1 and DDX3 are known to be required
for efficient Rev function in vivo, although their precise role is unknown. In
this study, single-molecule total internal reflection fluorescence (smTIRF) mi-
croscopy was used to visualize oligomeric assembly of Rev on the RRE with
single monomer resolution. Binding of up to eight fluorescently labeled Rev
monomers to a single immobilized RRE molecule was observed in real-time
as discrete jumps in fluorescence intensity, and the event frequencies and cor-
responding binding and dissociation rates for the different Rev-RRE stoichiom-
etries were determined. The smTIRF assay was used to study Rev-RRE
assembly in the presence of DDX1, DDX3 and other cellular proteins. The
presence of DDX1 promotes oligomeric assembly by accelerating the first
few Rev monomer binding steps, suggesting that DDX1 acts as a chaperone
of Rev. The smTIRF measurements are being extended to a multi-color format,
in order to directly visualize the colocalization of Rev and selected cellular pro-
teins on the same immobilized RRE molecules. These measurements are re-
vealing the precise timing of various protein binding events during
ribonucleoprotein assembly. Supported by NIH grant P50 GM082545.
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The hexahistidine (His6)/nickel(II)-nitrilotriacetic acid (Ni
2þ-NTA) system is
a universal tool for the affinity purification of recombinant proteins. Addition-
ally, the NTA group can be exploited for the attachment of fluorophores and
chromophores to His6 proteins at unique user-defined locations. The applica-
tions of one such derivative, (Ni2þ-NTA)2-Cy3 is characterized. The derivative
binds two model His6 proteins, N-ethylmaleimide sensitive factor (NSF) and
O6-alklyguanine-DNA alkyltransferase (AGT) with moderate affinity
(K~1.5x106M1). The activity of these proteins remains unaffected by the at-
tachment of the derivative. The (Ni2þ-NTA)2-Cy3 has high specificity which
makes it suitable for the detection of His6 proteins within complex mixtures
containing other proteins. This property allows the derivative to be used as
a probe of crude cell extracts and as a His6-specfic gel stain. The binding of
the (Ni2þ-NTA)2-Cy3 derivative is reversible in the presence of 10 mM ethyl-
enediaminetetraacetic acid (EDTA) or 500 mM imidazole, and in the absence
of such agents the exchange occurs slowly (kexchange~5x10
6S1 with 0.2 M
labeled protein in the presence of 1 M His6 peptide). The hydrodynamic prop-
erties can be explored with the attachment of the (Ni2þ-NTA)2-Cy3 derivative
utilizing fluorescent anisotropy or analytical ultracentrifugation within environ-
ments which prevent direct detection of the protein. Additionally, the (Ni2þ-
NTA)2-Cy3 derivative can be utilized during fluorescence resonance energy
